date:May 08, 2014
mmunosuppressive effects, but also species-specific clinical problems.
In 2013, Biomin became the first company to receive the European Commission authorization for feed additives with mycotoxin-counteracting properties. The authorizations were for the deoxynivalenol-biotransforming product Biomin BBSH 797 and the aflatoxin-binding bentonite Mycofix Secure.
FUMzyme, the result of years of intensive research at the Biomin Research Center in Austria, exemplifies the innovation lead of Biomin in